AXON Names New CEO, ANTH Awaits Data In Q3, Nicox Gets 2nd Chance From FDA

Nicox SA's resubmitted NDA for ZERVIATE for the treatment of ocular itching associated with allergic conjunctivitis has been accepted for review by the FDA - with a decision date set for September 8, 2017.

from RTT - Biotech http://ift.tt/2oZTOgc
via IFTTT